Abstract:Although combination antiretroviral therapy (ART) has been a landmark achievement for the treatment of human immunodeficiency virus (HIV), an HIV cure has remained elusive. Elimination of latent HIV reservoirs that persist throughout HIV infection is the most challenging barrier to an HIV cure. The progressive HIV infection is marked by the increasing size and diversity of latent HIV reservoirs until an effective immune response is mobilized, which can control but not eliminate HIV infection. The stalemate between HIV replication and the immune response is manifested by the establishment of a viral set point. ART initiation during the early stage limits HIV reservoir development, preserves immune function, improves the quality of life, and may lead to ART-free viral remission in a few people living with HIV (PLWH). However, for the overwhelming majority of PLWH, early ART initiation alone does not cure HIV, and lifelong ART is needed to sustain viral suppression. A critical area of research is focused on determining whether HIV could be functionally cured if additional treatments are provided alongside early ART. Several HIV interventions including Block and Lock, Shock and Kill, broadly neutralizing antibody (bNAb) therapy, adoptive CD8+ T cell therapy, and gene therapy have demonstrated delayed viral rebound and/or viral remission in animal models and/or some PLWH. Whether or not their application during early infection can improve the success of HIV remission is less studied. Herein, we review the current state of clinical and investigative HIV interventions and discuss their potential to improve the likelihood of post-treatment remission if initiated during early infection.

Functional cure for HIV:the approaches and challenges

Recent progress on functional cure for acquired immunodeficiency syndrome

Research progress on HIV latency-reversing agents and its mechanism

HIV-1 functional cure: will the dream come true?

Moving Toward a Functional Cure for HIV-1

Research progress and challenges on functional cure of AIDS

Advancements in Developing Strategies for Sterilizing and Functional HIV Cures

Insights into the HIV-1 Latent Reservoir and Strategies to Cure HIV-1 Infection

Strategies for human immunodeficiency virus cure：current status and future prospects

HIV Persistence, Latency, and Cure Approaches: Where Are We Now?

The neglected brain reservoirs：a barrier to an HIV cure

Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs

Editing out HIV: application of gene editing technology to achieve functional cure

The Rational Combination Strategy of Immunomodulatory Latency Reversing Agents and Novel Immunotherapy to Achieve HIV-1 Cure

Immune targeting of HIV-1 reservoir cells: a path to elimination strategies and cure

Research Progress on Human Immunodeficiency Virus Type 1 Latent Infection Activator

Interventions during Early Infection: Opening a Window for an HIV Cure?

Selective elimination of host cells harboring replication-competent human immunodeficiency virus reservoirs: a promising therapeutic strategy for HIV cure

Tat-Based Therapies as an Adjuvant for an HIV-1 Functional Cure

Latency reversal and viral clearance to cure HIV-1

HIV Reservoirs and Treatment Strategies toward Curing HIV Infection